{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4036, 
        4040
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4041, 
        4050
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3051, 
        3074
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4896, 
        4916
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3943, 
        3970
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3994, 
        3999
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4145, 
        4150
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4830, 
        4835
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4861, 
        4866
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1725, 
        1754
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2645, 
        2680
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4791, 
        4817
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4063, 
        4065
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4000, 
        4006
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4151, 
        4157
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4822, 
        4828
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4853, 
        4859
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4008, 
        4011
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4164, 
        4168
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4836, 
        4849
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4867, 
        4880
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3972, 
        3974
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4123, 
        4125
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4850, 
        4852
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 4^9999^MOH|PIMS|CCO|20160504000319|3D954690D0B41615E21B31B25BACEC86E49E72F8|ORU^R01|1605040003415537|P|2.5|||\nPID|1||9999999^^^^CMR^HOSPITAL 4&9999&MOH~9999999^^^^MRN^HOSPITAL 4&9999&MOH~9999999999&GK&^^^^JHN||XXXXXXX^XXXXX^^^^||99999999|F|^^^^^||999 XXXXXXX XXXXXX XXXX 999^^XXXXXXXXX^^X9X9X9^999||9999999999||||||||^^|||||||||N|||\nOBR|1||16:SH3616|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160420|||62522^XXXXX^XXXXXXX^XXXXXX^^^||||||||||||20160504|||C|||||||99999^XXXXXXXXX^XXXXXXXX^XXXXX^^^|\n\n\n\n\n\n\n\nPath Report.addendum spec\n\nAJCC/UICC                          CAP Version: Jan. 2015\n \n                                           \n              BREAST: Biomarker Reporting Template\n \nTests Performed:\n \n    Estrogen Receptor (ER) Status\n    Progesterone Receptor (PgR) Status\n    HER2 by Immunohistochemistry (IHC)\n \n   (ER) Results:Positive         Block: A.\n    Percentage of Cells with Nuclear Positivity: 100\n   Primary Antibody: ER EP1\n \n   (PgR) Results:Positive         Block: A.\n    Percentage of Cells with Nuclear Positivity: 70\n   Primary Antibody: PgR 636\n \n   HER2 IHC Results: Equivocal (2+) Block: A.\n    Percentage of Cells with Uniform Intense Complete Membrane Staining:0\n   Primary Antibody: HercepTest (A0485)\n \nCold Ischemia and Fixation Times: Meet requirements specified in latest version of\nthe ASCO/CAP.\nFixative: Formalin\n \nSH 3616-16A, selected block of tumour, needle core biopsy right breast - Using the\nantibody Hercep test against HER2/neu protein, the infiltrating carcinoma cells show\nindeterminate staining for HER2/neu 2. FISH analysis is pending. \nEstrogen receptor protein, Positive.\nProgesterone receptor protein, Positive.\n \n \nlje/vr\n\n\nPath report.gross description\n\nThe patient demographics and specimen identification on the requisition correspond to\nthat on the specimen container. The specimen is received in two containers, all of\nwhich are received in formalin.\n \nA. The container is labeled right breast core biopsy. Within the specimen container,\none cassette, labeled with the patient's last name, first initial on one side,\nbirthdate on the other. The cassette is labeled as to contain 3 cores. Submitted in\ntotal in its original cassette A for levels x3.\n \nB. The container is labeled right breast core biopsy. Within the specimen container,\none cassette, labeled with the patient's last name, first initial on one side,\nbirthdate on the other. The cassette is labeled as to contain 2 cores. Submitted in\ntotal in its original cassette B for levels x3.\n \nAt the time of embedding the MLT found 3 cores in cassette A and 2 cores in cassette\nB.\n\n\nPath report.microscopic observation\n\nA. The sections show an infiltrating duct carcinoma, NOS, grade II (preliminary\ngrade).\n \nB. The sections show DCIS , nuclear grade 2, involving an area of sclerosing adenosis\nwith evidence of microcalcifications. This lesion is predominantly not present at the\ndeeper levels done for immunohistochemistry. Hence the coexisting invasive carcinoma\ncannot be excluded.\n\n\nPath report.relevant Hx\n\nCase Received From: BAC - Ultrasound\nRadiologist: Dr. C. Otero\nClinical Exam: A-palpable; B-Nonpalpable\nReferral Source: JCC, Surgeon BAC\nFamily History: Yes - patient had breast cancer previously\nHormone Replacement: Yes - unknown medication  unknown # of years\nPrevious Biopsy: No\nImaging Modality: Ultrasound\nNumber of Cores: A-3; B-2\nNumber of Cassettes: A-1; B-1\nRadiology Findings: A-mass, obscured border; B-mass, well circumscribed, clip placed\n           A  B 3.9 cm apart\nLesion(s) Measurements:  A=1.6 x 1.2 x 1.1 cm; B=0.8 x 0.2 x 0.5 cm\nIs Sample Representative: A B-Yes\nCalcifications in Sample: N/A\nNo. of cores with calcification: N/A\nNo. of cassettes with calcification: N/A\nRadiologic Impression: BIRADS - A-5; B-4A\nPathologic Category: P5\nMultidisciplinary Panel Recommendations: Returns to attending attending oncologist\nLymph Node Scanned: Yes\n\n\nPath report.final diagnosis\n\nA. Needle core biopsy right breast, mid, 7:00\n   - Infiltrating duct carcinoma, NOS, grade II (preliminary grade).\n   - ER, PR, HER-2/neu, pending\n \n \nB. Needle core biopsy right breast, mid, 6:00, retroareolar\n   - Ductal carcinoma in situ changes, nuclear grade 2, involving and area\nsclerosing adenosis\n   - A coexisting invasive carcinoma cannot be excluded\n \n****************PATHOLOGIC/RADIOLOGIC CORRELATION*************\n \nTHE SECIONS OF THIS CASE HAS BEEN REVIEWED BY THE PATHOLOGY/RADIOLOGY PANEL AND\nCORRELATED WITH THE RADIOLOGIC FINDINGS. RADIOLOGY PANEL CONSISTS OF DR. T.MINUK AND\nA. THOMSON\n \nTHE RADIOLOGICAL/PATHOLOGICAL FINDINGS: Correlate (see note below)\n \nRECOMMENDATION OF MULTIDISCIPLINARY PANEL: Returns to attending oncologist\n \nNote: The radiological findings indicate \"multicentric disease\"\n\n\nPath report.site of origin\n\nA: Breast, right mid 7 o'clock\nB: Breast, right mid 6 o'clock retroareolar\n\n\nPath report.comments\n\nISCHEMIC SPECIMEN TYPE Breast Core Biopsy\nISCHEMIC SPECIMEN TYPE 2 Breast Core Biopsy\nISCHEMIC DATE PROCESSED 21/04/16\nDATE IN FORMALIN 20/04/16\nDATE IN FORMALIN 2 20/04/16\nDATE TISSUE REMOVED 20/04/16\nDATE TISSUE REMOVED 2 20/04/16\nISCHEMIC SIDE A. Right mid 7 o'clock\nISCHEMIC SIDE 2 B. Right mid 6 o'clock retroareolar\nISCHEMIC SIGNATURE RY\nTIME IN FORMALIN 1356\nTIME IN FORMALIN 2 1410\nTOTAL FIXATION TIME 24-48 hours\nTIME TISSUE REMOVED 1350\nTIME TISSUE REMOVED 2 1400\n\n\n"
}